SG11201408055PA - Stable pexiganan formulation - Google Patents
Stable pexiganan formulationInfo
- Publication number
- SG11201408055PA SG11201408055PA SG11201408055PA SG11201408055PA SG11201408055PA SG 11201408055P A SG11201408055P A SG 11201408055PA SG 11201408055P A SG11201408055P A SG 11201408055PA SG 11201408055P A SG11201408055P A SG 11201408055PA SG 11201408055P A SG11201408055P A SG 11201408055PA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- june
- pct
- pexiganan
- unless
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/494,295 US8530409B1 (en) | 2012-06-12 | 2012-06-12 | Stable pexiganan formulation |
| PCT/US2013/044957 WO2013188286A1 (en) | 2012-06-12 | 2013-06-10 | Stable pexiganan formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201408055PA true SG11201408055PA (en) | 2015-01-29 |
Family
ID=49084089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201408055PA SG11201408055PA (en) | 2012-06-12 | 2013-06-10 | Stable pexiganan formulation |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8530409B1 (es) |
| EP (1) | EP2858721B1 (es) |
| JP (1) | JP5876191B2 (es) |
| KR (1) | KR101622524B1 (es) |
| CN (1) | CN104602762B (es) |
| AU (1) | AU2013274561B2 (es) |
| BR (1) | BR112014030993A2 (es) |
| CA (1) | CA2876668C (es) |
| CY (1) | CY1118277T1 (es) |
| DK (1) | DK2858721T3 (es) |
| EA (1) | EA028002B1 (es) |
| ES (1) | ES2599395T3 (es) |
| HK (1) | HK1210078A1 (es) |
| HR (1) | HRP20161440T1 (es) |
| HU (1) | HUE030665T2 (es) |
| IL (1) | IL236151A (es) |
| LT (1) | LT2858721T (es) |
| MX (1) | MX345263B (es) |
| NZ (1) | NZ703176A (es) |
| PL (1) | PL2858721T3 (es) |
| PT (1) | PT2858721T (es) |
| RS (1) | RS55286B1 (es) |
| SG (1) | SG11201408055PA (es) |
| SI (1) | SI2858721T1 (es) |
| SM (1) | SMT201600411B (es) |
| WO (1) | WO2013188286A1 (es) |
| ZA (1) | ZA201500117B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8530409B1 (en) * | 2012-06-12 | 2013-09-10 | Dipexium Pharmaceuticals LLC | Stable pexiganan formulation |
| GB201505393D0 (en) * | 2015-03-30 | 2015-05-13 | Secr Defence | Antimicrobal peptide formulations |
| CN111925430B (zh) * | 2020-08-18 | 2022-05-24 | 中国海洋大学 | 抗菌肽及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| US4169703A (en) * | 1978-08-03 | 1979-10-02 | Syntex (U.S.A.) Inc. | Oxidative red hair dye |
| US5912231A (en) * | 1989-07-07 | 1999-06-15 | Scripps Clinic And Research Foundation | Substitution analogues of magainin peptides |
| TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
| US7530461B2 (en) * | 1995-03-10 | 2009-05-12 | Photocure Asa | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| EP1734925A2 (en) * | 2004-03-18 | 2006-12-27 | Panacea Biotec Ltd. | Novel compositions for topical delivery |
| US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| WO2009070564A2 (en) * | 2007-11-27 | 2009-06-04 | Macrochem Corporation | Compositions and methods for prevention of infection in transcutaneous osseointegrated implants |
| US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| WO2012174373A1 (en) * | 2011-06-16 | 2012-12-20 | Dipexium Pharmaceuticals | Methods of treating and inhibiting pathogens with resistance-mechanisms |
| US8530409B1 (en) * | 2012-06-12 | 2013-09-10 | Dipexium Pharmaceuticals LLC | Stable pexiganan formulation |
-
2012
- 2012-06-12 US US13/494,295 patent/US8530409B1/en not_active Expired - Fee Related
-
2013
- 2013-06-10 PT PT138036561T patent/PT2858721T/pt unknown
- 2013-06-10 ES ES13803656.1T patent/ES2599395T3/es active Active
- 2013-06-10 NZ NZ703176A patent/NZ703176A/en not_active IP Right Cessation
- 2013-06-10 HU HUE13803656A patent/HUE030665T2/en unknown
- 2013-06-10 SI SI201330366A patent/SI2858721T1/sl unknown
- 2013-06-10 BR BR112014030993A patent/BR112014030993A2/pt not_active IP Right Cessation
- 2013-06-10 WO PCT/US2013/044957 patent/WO2013188286A1/en active Application Filing
- 2013-06-10 LT LTEP13803656.1T patent/LT2858721T/lt unknown
- 2013-06-10 CN CN201380031162.5A patent/CN104602762B/zh not_active Expired - Fee Related
- 2013-06-10 AU AU2013274561A patent/AU2013274561B2/en not_active Ceased
- 2013-06-10 JP JP2015517332A patent/JP5876191B2/ja not_active Expired - Fee Related
- 2013-06-10 RS RS20160918A patent/RS55286B1/sr unknown
- 2013-06-10 DK DK13803656.1T patent/DK2858721T3/en active
- 2013-06-10 KR KR1020157000319A patent/KR101622524B1/ko not_active IP Right Cessation
- 2013-06-10 SG SG11201408055PA patent/SG11201408055PA/en unknown
- 2013-06-10 EP EP13803656.1A patent/EP2858721B1/en active Active
- 2013-06-10 CA CA2876668A patent/CA2876668C/en not_active Expired - Fee Related
- 2013-06-10 EA EA201492280A patent/EA028002B1/ru not_active IP Right Cessation
- 2013-06-10 MX MX2014015199A patent/MX345263B/es active IP Right Grant
- 2013-06-10 PL PL13803656T patent/PL2858721T3/pl unknown
- 2013-08-09 US US13/963,311 patent/US20140038882A1/en not_active Abandoned
-
2014
- 2014-12-09 IL IL236151A patent/IL236151A/en not_active IP Right Cessation
-
2015
- 2015-01-08 ZA ZA2015/00117A patent/ZA201500117B/en unknown
- 2015-11-02 HK HK15110786.0A patent/HK1210078A1/xx not_active IP Right Cessation
-
2016
- 2016-10-19 CY CY20161101058T patent/CY1118277T1/el unknown
- 2016-11-02 HR HRP20161440TT patent/HRP20161440T1/hr unknown
- 2016-11-15 SM SM201600411T patent/SMT201600411B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811549UA (en) | Boronic acid derivatives and therapeutic uses thereof | |
| SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
| SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
| SG11201408174UA (en) | Antibody formulation | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201804170RA (en) | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201408124PA (en) | Differentiation of human embryonic stem cells into pancreatic endocrine cells | |
| SG11201408261UA (en) | Syringe | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201806583XA (en) | Compositions containing tucaresol or its analogs | |
| SG11201407228PA (en) | N-aryltriazole compounds as lpar antagonists | |
| SG11201408769QA (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
| SG11201408318RA (en) | Compositions and methods for transmucosal absorption | |
| SG11201408173WA (en) | Pyrimidinyl tyrosine kinase inhibitors | |
| SG11201901438VA (en) | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201805368YA (en) | Anthelmintic depsipeptide compounds | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
| SG11201810429UA (en) | Anti-cd19 antibody formulations | |
| SG11201408509PA (en) | Racecadotril lipid compositions | |
| SG11201408333UA (en) | Bulk purchasing by ad hoc consumer groups |